BRCA1 and breast cancer: In terms of activity, trabectedin seems particularly attractive in BC with DNA damage repair defects and especially in BRCA1/2 mutated germline tumours and in the so-called sporadic “BRCAness” BC with specific somatic gene alterations (Peto et al., 1999).